St. John's, Newfoundland--(Newsfile Corp. - September 2, 2025) - Sokoman Minerals Corp. (TSXV: SIC) (OTCQB: SICNF) ("Sokoman" or the "Company") further to its August 14, 2025 news release, Sokoman is pleased to announce that it has signed 2 property purchase agreements, expanding its land position at Crippleback Lake in Central Newfoundland.The Company has agreed to purchase a 100% undivided interest in 105 mineral claims located in the Crippleback Lake Area from United Gold Inc. (the United Gold Claims). ...

Core Viewpoint - Pineapple Financial Inc. has announced a $100 million private placement to launch the first digital asset treasury strategy anchored in INJ, the native asset of Injective, positioning itself as the first publicly traded INJ holder globally [2][6][7] Group 1: Company Strategy and Positioning - The INJ treasury strategy is expected to generate a passive yield of approximately 12%, one of the higher yields across major blockchain networks [3] - By focusing on an INJ-first strategy, the company aims to explore how blockchain-based assets can advance the financial industry, aligning with the multi-trillion-dollar tokenization trend [3][4] - The transaction drew participation from leading investors across traditional finance and crypto, indicating strong confidence in Pineapple's strategy and Injective's potential [6][9] Group 2: Industry Context and Future Outlook - The Injective blockchain has powered over $60 billion in transactions and is experiencing strong adoption, with usage surging more than 1,000% year to date [4] - The investment into INJ is seen as a way to address structural challenges in traditional financial processes, promoting speed, efficiency, and transparency [8] - The move is viewed as a significant step towards merging traditional finance with blockchain technology, potentially transforming the financial landscape [4][7]

Kadestone Enters into Definitive Agreement to Acquire BC-Based Real Estate Development CompanySeptember 02, 2025 9:15 AM EDT | Source: Kadestone Capital Corp.Vancouver, British Columbia--(Newsfile Corp. - September 2, 2025) - Kadestone Capital Corp. (TSXV: KDSX) (OTCQB: KDCCF) ("Kadestone" or the "Company") is pleased to announce that it has entered into a purchase agreement (the "Purchase Agreement") with Attollo Management Inc. ("Attollo"), a private development firm led by renowned real est ...

Core Insights - SonicStrategy Inc. has secured a $40 million USD ($55 million CAD) investment from Sonic Labs Ltd, which oversees the Sonic blockchain ecosystem, reinforcing their long-term partnership and paving the way for additional institutional capital as the company aims for a Nasdaq Capital Markets listing [1][2][7] Investment Structure - The investment is structured as a convertible debt instrument funded in Sonic tokens, with a six-month term and a conversion price of $4.50 USD ($6.22 CAD) per common share, contingent upon certain milestones including the Nasdaq listing [2][5] - The debt is unsecured, non-interest-bearing, and any equity issued upon conversion will be subject to a three-year lock-up [5] Strategic Implications - The investment is intended to strengthen SonicStrategy's treasury, scale validator operations, and support early-stage Sonic-based projects, aligning with the company's mission to bridge the Sonic ecosystem with global capital markets [3][7] - Sonic tokens provided by Sonic Labs will be locked for four years, ensuring long-term alignment between the two organizations [3] Future Prospects - The capital raised will be utilized for treasury, validator operations, blockchain investments, and working capital, setting the stage for SonicStrategy's application to list on the Nasdaq, subject to regulatory approval [2][5] - SonicStrategy is positioned as a bridge between the Sonic Network and traditional finance, enhancing its institutional credibility and global visibility [7]

BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ETSeptember 02, 2025 8:30 AM EDT | Source: BioHarvest Sciences Inc.Rehovot, Israel--(Newsfile Corp. - September 2, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management will host a Virtual Investor Webinar on Wednesday, September 10, 2025 at 1:00 p.m. Eastern time ...

Financial Results - For the three months ended June 30, 2025, the company reported an adjusted working capital of $(432,275) and an adjusted EBITDA of $(2,870,115) [2] - The net loss from continuing operations was $(552,605), equating to $(0.01) per share [2] - Average daily production was recorded at 1,060 barrels of oil equivalent per day (boepd) [2] Ecuador Operations - The company is part of a consortium that has reached an agreement for a production sharing contract (PSC) for Block 60 in Ecuador, with a proposed 40% working interest [4] - Following the inauguration of President Noboa, discussions with the Ecuadorian government have resumed regarding the PSC [5] Brazil Developments - A memorandum of understanding (MOU) was signed with Vultur Oils on August 5, 2025, to develop two concession contracts in Bahia, Brazil [6][7] - The blocks are adjacent to Petrobras' Araças field, which has produced approximately 5.9 million barrels of oil equivalent since 2012 [8] - If investments are completed, the company could have gross proved reserves of 3.07 million BOE with a net present value (NPV10) of $32.83 million [9] Peru Initiatives - A formal application was submitted to operate and invest in Block 192 in Peru, which has been shut in since 2021 [11][13] - The technical team previously operated Block 192, achieving production of over 15,000 boepd during their tenure [12] Mexico Operations - For the six months ended June 30, 2025, Operaciones Petroleras Soledad reported net income of $1,127,224, with $778,468 attributable to the company's 49% equity interest [14] - Negotiations are ongoing with Pemex regarding a potential migration from the existing oil and gas contract to a mixed contract structure [15] Private Placement - The company announced a non-brokered private placement of 25,090,909 common shares at CAD$0.55 per share, aiming for gross proceeds of up to CAD$13,800,000 (approximately USD$10,000,000) [17][18]

Core Viewpoint - OS Therapies is progressing towards the submission of a rolling Biologics Licensing Application (BLA) for its OST-HER2 program targeting recurrent, fully resected, pulmonary metastatic osteosarcoma, following a productive End of Phase 2 meeting with the FDA [1][2][6] Group 1: FDA Meeting Outcomes - The FDA and OS Therapies reached alignment on several critical areas necessary for a successful BLA, including clinical trial efficacy endpoints and statistical analysis plans [2] - A public meeting with key osteosarcoma stakeholders is scheduled for October 10, 2025, to discuss advancing drug development for osteosarcoma [2] - The FDA is committed to working closely with the Company, prioritizing both formal and informal meetings, with the first informal meeting set for mid-September 2025 [2][6] Group 2: Clinical Data and Safety Profile - No significant safety concerns were identified for OST-HER2 based on the clinical data available to date, indicating an excellent safety profile [3] - The Company is preparing necessary data for submission to the FDA as part of the rolling BLA submission expected in Q4 2025 [3] Group 3: Designations and Financial Aspects - OST-HER2 has received Rare Pediatric Disease Designation (RPDD) and is eligible for a Prescription Drug User Fee Act (PDUFA) small business fee waiver, with a decision expected by the end of Q3 2025 [5][7] - The Company anticipates significant progress towards Breakthrough Therapy designation (BTD) and either Accelerated Approval or full approval during the upcoming FDA/OSI workshop [4] Group 4: Future Developments - OS Therapies is also advancing its next-generation Antibody Drug Conjugate (ADC) platform, known as tunable ADC (tADC), which utilizes proprietary technology for enhanced treatment delivery [8] - The Company is actively compiling data for the OST-400 natural history database to support the development of a synthetic control arm for future trials [2][6]

Core Insights - Atlas Critical Minerals Corporation expects to generate initial revenues from its Iron Quadrangle Project in the fourth quarter of 2025, facilitated by a strategic partnership with a Brazilian iron ore processor [1][5]. Company Overview - Atlas Critical Minerals controls a significant portfolio of critical mineral rights in Brazil, covering over 218,000 hectares, which includes projects in rare earths, titanium, and graphite [5]. - The Iron Quadrangle Project is located in the Minas Gerais region, a key iron ore district in Brazil, and encompasses approximately 55,057 acres across 18 mineral rights [4][5]. Project Development - The company has undertaken detailed geological exploration, including a drilling campaign covering about 10% of the mineral rights, leading to an initial technical report summary published in 2022 [4]. - In May 2024, Atlas received a 10-year operational license, followed by mining concession status from the Ministry of Mines and Energy in May 2025 [4]. Revenue Generation Strategy - The mining will be conducted via open-pit methods, with an independent Brazilian company processing the extracted iron ore into high-quality sinter feed, allowing Atlas to receive revenues from both run-of-mine material and a percentage of the final product [1][3]. - The company anticipates that this model will lead to immediate profitability and enable reinvestment into the development of its critical minerals portfolio [3].

ONGold Initiates Infill Sampling Program to Recover Missing Tungsten and Gold Assays at Monument Bay for Enhanced Resource Modeling and DevelopmentSeptember 02, 2025 7:30 AM EDT | Source: ONGold Resources Ltd.Toronto, Ontario--(Newsfile Corp. - September 2, 2025) - ONGold Resources Ltd. (TSXV: ONAU) (OTCQB: ONGRF) ("ONGold") is pleased to announce that the company has initiated an infill sampling program targeting intervals not previously sampled for tungsten and gold throughout the Monument B ...

Core Viewpoint - Dexterra Group Inc. has successfully completed the acquisition of Right Choice Camps & Catering, enhancing its capacity and growth potential in the workforce accommodations sector in Canada [1][2]. Company Overview - Dexterra employs over 9,000 people and provides a variety of support services for infrastructure management and operations across Canada and the U.S. [2]. - The company specializes in integrated facilities management services and workforce accommodation solutions for both public and private sector clients [3]. Acquisition Details - The acquisition of Right Choice Camps & Catering was finalized on August 31, 2025, and is expected to strengthen Dexterra's market position [1]. - The integration of Right Choice's operations and equipment is anticipated to contribute to long-term growth for Dexterra [2].